A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
Active, not recruiting · NCT04808245 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-09-15 | NCT04808245 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Charite University, Berlin, Germany | 188 |
| German Cancer Aid | 6 |
| German Cancer Research Center | 47 |
| Johannes Gutenberg University Mainz | 34 |
| Roche Pharma AG | 59 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinic and Polyclinic for Neurosurgery, University Hospital Carl Gustav Carus Dresden | Dresden | Germany | 1 |
| Clinical Neuro-Oncology Section, University Hospital Bonn (UKB) | Bonn | Germany | 1 |
| Department of Neurology and Polyclinic, Universitiy Clinic Heidelberg | Heidelberg | Germany | 1 |
| Department of Neurosurgery with Pediatric Neurosurgery | Berlin | Germany | 1 |
| Dr. Senckenberg Institute for Neurooncology, University Hospital Frankfurt | Frankfurt am Main | Germany | 1 |
| Neurooncology Department, University Hospital Essen | Essen | Germany | 1 |
| University Clinic Tuebingen, Neurological Clinic, Department of Neurology | Tübingen | Germany | 1 |
| University Medical Center Mannheim, Department of Neurology | Mannheim | Germany | 1 |